BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16227779)

  • 1. Transdermal clonidine: therapeutic considerations.
    Sica DA; Grubbs R
    J Clin Hypertens (Greenwich); 2005 Sep; 7(9):558-62. PubMed ID: 16227779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One year efficacy and tolerability of clonidine administered by the transdermal route in patients with mild to moderate essential hypertension--a multicentre open label study. The Antihypertensive Patch Italian Study (APIS) Investigators.
    Clin Auton Res; 1993 Dec; 3(6):379-83. PubMed ID: 8193525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term (5 year) experience with transdermal clonidine in the treatment of mild to moderate hypertension.
    Breidthardt J; Schumacher H; Mehlburger L
    Clin Auton Res; 1993 Dec; 3(6):385-90. PubMed ID: 8193526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal antihypertensive therapy: clinical and metabolic considerations.
    Weber MA
    Am Heart J; 1986 Oct; 112(4):906-12. PubMed ID: 2945415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of two different galenic formulations of a transdermal clonidine system in the treatment of hypertension.
    Kolloch RE; Mehlburger L; Schumacher H; Göbel BO
    Clin Auton Res; 1993 Dec; 3(6):373-8. PubMed ID: 8193524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The USA experience with the clonidine transdermal therapeutic system.
    Burris JF
    Clin Auton Res; 1993 Dec; 3(6):391-6. PubMed ID: 8193527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of transdermal clonidine and oral atenolol on acute exercise performance and response to aerobic conditioning in subjects with hypertension.
    Davies SF; Graif JL; Husebye DG; Maddy MM; McArthur CD; Path MJ; O'Connell MB; Iber C; Davidman M
    Arch Intern Med; 1989 Jul; 149(7):1551-6. PubMed ID: 2525897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin reactions to long-term transdermal clonidine.
    Dick JB; Northridge DB; Lawson AA
    Lancet; 1987 Feb; 1(8531):516. PubMed ID: 2881081
    [No Abstract]   [Full Text] [Related]  

  • 9. Transdermal clonidine. A preliminary review of its pharmacodynamic properties and therapeutic efficacy.
    Langley MS; Heel RC
    Drugs; 1988 Feb; 35(2):123-42. PubMed ID: 3281820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment with transdermal clonidine in mild hypertension.
    Fillingim JM; Matzek KM; Hughes EM; Johnson PA; Sharon GS
    Clin Ther; 1989; 11(3):398-408. PubMed ID: 2743374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin pretreatment and the use of transdermal clonidine.
    Ito MK; O'Connor DT
    Am J Med; 1991 Jul; 91(1A):42S-49S. PubMed ID: 1831005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal administration of clonidine: a new approach to antihypertensive therapy.
    Burris JF; Mroczek WJ
    Pharmacotherapy; 1986; 6(1):30-4. PubMed ID: 3952004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergic contact dermatitis from transdermal clonidine in a patient with mycosis fungoides.
    Polster AM; Warner MR; Camisa C
    Cutis; 1999 Mar; 63(3):154-5. PubMed ID: 10190065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical acceptability of transdermal clonidine: a large-scale evaluation by practitioners.
    Hollifield J
    Am Heart J; 1986 Oct; 112(4):900-6. PubMed ID: 2945414
    [No Abstract]   [Full Text] [Related]  

  • 15. Transdermal clonidine as an adjunct to sustained-release diltiazem in the treatment of mild-to-moderate hypertension.
    Lueg MC; Herron J; Zellner S
    Clin Ther; 1991; 13(4):471-81. PubMed ID: 1933999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of menopausal hot flashes with transdermal administration of clonidine.
    Nagamani M; Kelver ME; Smith ER
    Am J Obstet Gynecol; 1987 Mar; 156(3):561-5. PubMed ID: 3826200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transdermal clonidine: a new therapeutic approach in essential hypertension?].
    Groth H; Greminger P; Vetter H; Knüsel J; Baumgart P; Siegenthaler W; Vetter W
    Schweiz Rundsch Med Prax; 1985 Mar; 74(11):265-9. PubMed ID: 3158058
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of clonidine as transdermal therapeutic system: the international clinical trial experience.
    Lowenthal DT; Saris S; Paran E; Cristal N; Sharif K; Bies C; Fagan T
    Am Heart J; 1986 Oct; 112(4):893-900. PubMed ID: 3532747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
    Ishii R; Tagawa T; Ishida T; Naruse T
    Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal clonidine as an adjunct to nifedipine-GITS therapy in patients with mild-to-moderate hypertension.
    Houston MC; Hays L
    Am Heart J; 1993 Oct; 126(4):918-23. PubMed ID: 8213450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.